Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial
Author:
Funder
National Natural Science Foundation of China
Science and Technology Commission of Shanghai Municipality
Shanghai Shenkang Hospital Development Center
Publisher
Elsevier BV
Reference34 articles.
1. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders;Aron-Wisnewsky;Nat. Rev. Gastroenterol. Hepatol.,2020
2. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota;Boursier;Hepatology,2016
3. Gut microbial metabolites in obesity, NAFLD and T2DM;Canfora;Nat. Rev. Endocrinol.,2019
4. Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis;Chen;Pharmacol. Res.,2021
5. A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease;Cheng;Nat. Commun.,2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3